REVVITY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.6 USD | -0.46% |
|
-0.89% | -7.96% |
| Apr. 30 | TD Cowen Adjusts Price Target on Revvity to $130 From $123 | MT |
| Apr. 30 | JPMorgan Adjusts Price Target on Revvity to $105 From $100, Neutral Rating Maintained | MT |
Presenter SpeechThomas Peterson (Analysts)Thanks, everyone. Welcome. Thank you for joining. I'...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Revvity, Inc. (formerly PerkinElmer, Inc.) specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales (including intragroup) break down by family of products as follows:
- medical diagnosis equipment (61%);
- analytical tools and instruments (39%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc.
Net sales are distributed geographically as follows: the United States (46.7%), China (14.4%), the United Kingdom (4.1%) and other (34.8%).
Calendar
2024-05-14
- BofA Securities Health Care Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
100.6
USD
Average target price
123.6
USD
Spread / Average Target
+22.86%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.96% | 12.43B | |
| +7.84% | 218B | |
| +7.35% | 184B | |
| +13.04% | 135B | |
| +26.03% | 107B | |
| -1.33% | 62.38B | |
| +11.80% | 51.37B | |
| +4.81% | 50.9B | |
| +0.30% | 40.87B | |
| +2.78% | 36.28B |
- Stock Market
- Equities
- RVTY Stock
- News Revvity, Inc.
- Transcript : PerkinElmer, Inc. Presents at Baird 2022 Global Healthcare Conference, Sep-13-2022 10
